Valneva shares fall as French well being physique advises in opposition to its COVID-19 vaccine
PARIS, Dec 8 (Reuters) – Shares in France’s Valneva (VLS.PA) reversed course on the Paris inventory market and traded down by round 2.8% after the nation’s public well being authority stated it will advise the federal government to not use the corporate’s COVID-19 vaccine for its vaccination technique.
Reporting by Tassilo Hummel; Enhancing by Sudip Kar-Gupta
Our Requirements: The Thomson Reuters Trust Principles.
Source link